METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENTECAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC

Objective: The objective and purpose of the analysis have sensibly assessed by selecting of a rapid and sensitive RP-HPLC method for Entecavir in bulk and pharmaceutical dosage form by using the most commonly employed C-18column with UV detection.Methods: In estimation by RP-HPLC method Agilent 1120...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of current pharmaceutical research 2017-09, p.107-111
Hauptverfasser: P., Swathi, Vidyadhara, S., Sasidhar, R. L. C., Chakravarthi, K. Kalyan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111
container_issue
container_start_page 107
container_title International journal of current pharmaceutical research
container_volume
creator P., Swathi
Vidyadhara, S.
Sasidhar, R. L. C.
Chakravarthi, K. Kalyan
description Objective: The objective and purpose of the analysis have sensibly assessed by selecting of a rapid and sensitive RP-HPLC method for Entecavir in bulk and pharmaceutical dosage form by using the most commonly employed C-18column with UV detection.Methods: In estimation by RP-HPLC method Agilent 1120 compact LC system with variable programmable UV detector and Rheodyne injector with 20 µl fixed loop was used for the chromatographic separation. The mode of operation was isocratic with the components of a solution consisting of methanol: acetonitrile(70:30v/v) and triethanolamine (2-4drops)at the flow rate of 1.2 ml/min and run time was 10 min. Forced degradation studies were conducted to evaluate the stability and specificity of the method along with the validation parameters.Results: Validation parameters of HPLC were found at a detection wavelength of 255 nm. Linearity was observed with the concentration range (Beer’s law range) 20-100µg/ml with R2=0.9991. Robustness with detection wavelengths 253 and 257 nm with a flow rate of 1 ml/min and 1.4 ml/min showed good results. The retention time of the drug was 2.64 min and assay showed 98.1%.Conclusion: The proposed RP-HPLC method was validated as per the ICH Q2B Guidelines, and was found to be applicable for routine quantitative analysis of Entecavir by RP-HPLC using UV detector in pharmaceutical dosage forms. The results of linearity, precision, accuracy and specificity, were proved, that does not exceed certain specified limits. The method provides selective quantification with no interference from other formulation excipients. The proposed method was highly sensitive, reproducible, reliable, robust and specific. Therefore, this method is a simple, rapid analysis may actually be more desirable than a more complicated and time-consuming process. The degradation studies at various stress conditions like thermal and hydrolytic, drug gets degraded at a temperature of 80 °c and refluxing with water at 70 °c for 24hours. 
doi_str_mv 10.22159/ijcpr.2017v9i5.22151
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_22159_ijcpr_2017v9i5_22151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_22159_ijcpr_2017v9i5_22151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c981-c8e68cc9505ab99fdcdf4c5e7e19e4d43aac046cc822481ec47e3acdc4aad3513</originalsourceid><addsrcrecordid>eNpNkNFqgzAUhsPYYKXrIwzyAnaJJmouU02rTI3YtLAryY4RWjZWdAz29l3tBrs6h4___y8-hB4pWfo-5eLpcITTsPQJjb7EgU-Q3qAZERH3IhKGt__-e7QYxyMhxKeRiMJ4hj5LZTKd4lTtVaHrUlUGyyrFe1nkqTS5rvBaN9hkCqutycsr0mv8E1SJ3OcNziu82hXPU63OZFPKRO1MnsgCp3orN-qyUG7x6gU3tZfVRfKA7nr7NrrF750js1YmybxCby49D0RMPYhdGAMITrh9FaLvoOsZcBc5KhzrWGAtEBYCxL7PYuqARS6w0AGztgs4DeaIX2dh-BjHwfXtaTi82-G7paSd5LWTvPZP3gRpcAbOXlwC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENTECAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>P., Swathi ; Vidyadhara, S. ; Sasidhar, R. L. C. ; Chakravarthi, K. Kalyan</creator><creatorcontrib>P., Swathi ; Vidyadhara, S. ; Sasidhar, R. L. C. ; Chakravarthi, K. Kalyan</creatorcontrib><description>Objective: The objective and purpose of the analysis have sensibly assessed by selecting of a rapid and sensitive RP-HPLC method for Entecavir in bulk and pharmaceutical dosage form by using the most commonly employed C-18column with UV detection.Methods: In estimation by RP-HPLC method Agilent 1120 compact LC system with variable programmable UV detector and Rheodyne injector with 20 µl fixed loop was used for the chromatographic separation. The mode of operation was isocratic with the components of a solution consisting of methanol: acetonitrile(70:30v/v) and triethanolamine (2-4drops)at the flow rate of 1.2 ml/min and run time was 10 min. Forced degradation studies were conducted to evaluate the stability and specificity of the method along with the validation parameters.Results: Validation parameters of HPLC were found at a detection wavelength of 255 nm. Linearity was observed with the concentration range (Beer’s law range) 20-100µg/ml with R2=0.9991. Robustness with detection wavelengths 253 and 257 nm with a flow rate of 1 ml/min and 1.4 ml/min showed good results. The retention time of the drug was 2.64 min and assay showed 98.1%.Conclusion: The proposed RP-HPLC method was validated as per the ICH Q2B Guidelines, and was found to be applicable for routine quantitative analysis of Entecavir by RP-HPLC using UV detector in pharmaceutical dosage forms. The results of linearity, precision, accuracy and specificity, were proved, that does not exceed certain specified limits. The method provides selective quantification with no interference from other formulation excipients. The proposed method was highly sensitive, reproducible, reliable, robust and specific. Therefore, this method is a simple, rapid analysis may actually be more desirable than a more complicated and time-consuming process. The degradation studies at various stress conditions like thermal and hydrolytic, drug gets degraded at a temperature of 80 °c and refluxing with water at 70 °c for 24hours. </description><identifier>ISSN: 0975-7066</identifier><identifier>EISSN: 0975-7066</identifier><identifier>DOI: 10.22159/ijcpr.2017v9i5.22151</identifier><language>eng</language><ispartof>International journal of current pharmaceutical research, 2017-09, p.107-111</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c981-c8e68cc9505ab99fdcdf4c5e7e19e4d43aac046cc822481ec47e3acdc4aad3513</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>P., Swathi</creatorcontrib><creatorcontrib>Vidyadhara, S.</creatorcontrib><creatorcontrib>Sasidhar, R. L. C.</creatorcontrib><creatorcontrib>Chakravarthi, K. Kalyan</creatorcontrib><title>METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENTECAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC</title><title>International journal of current pharmaceutical research</title><description>Objective: The objective and purpose of the analysis have sensibly assessed by selecting of a rapid and sensitive RP-HPLC method for Entecavir in bulk and pharmaceutical dosage form by using the most commonly employed C-18column with UV detection.Methods: In estimation by RP-HPLC method Agilent 1120 compact LC system with variable programmable UV detector and Rheodyne injector with 20 µl fixed loop was used for the chromatographic separation. The mode of operation was isocratic with the components of a solution consisting of methanol: acetonitrile(70:30v/v) and triethanolamine (2-4drops)at the flow rate of 1.2 ml/min and run time was 10 min. Forced degradation studies were conducted to evaluate the stability and specificity of the method along with the validation parameters.Results: Validation parameters of HPLC were found at a detection wavelength of 255 nm. Linearity was observed with the concentration range (Beer’s law range) 20-100µg/ml with R2=0.9991. Robustness with detection wavelengths 253 and 257 nm with a flow rate of 1 ml/min and 1.4 ml/min showed good results. The retention time of the drug was 2.64 min and assay showed 98.1%.Conclusion: The proposed RP-HPLC method was validated as per the ICH Q2B Guidelines, and was found to be applicable for routine quantitative analysis of Entecavir by RP-HPLC using UV detector in pharmaceutical dosage forms. The results of linearity, precision, accuracy and specificity, were proved, that does not exceed certain specified limits. The method provides selective quantification with no interference from other formulation excipients. The proposed method was highly sensitive, reproducible, reliable, robust and specific. Therefore, this method is a simple, rapid analysis may actually be more desirable than a more complicated and time-consuming process. The degradation studies at various stress conditions like thermal and hydrolytic, drug gets degraded at a temperature of 80 °c and refluxing with water at 70 °c for 24hours. </description><issn>0975-7066</issn><issn>0975-7066</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpNkNFqgzAUhsPYYKXrIwzyAnaJJmouU02rTI3YtLAryY4RWjZWdAz29l3tBrs6h4___y8-hB4pWfo-5eLpcITTsPQJjb7EgU-Q3qAZERH3IhKGt__-e7QYxyMhxKeRiMJ4hj5LZTKd4lTtVaHrUlUGyyrFe1nkqTS5rvBaN9hkCqutycsr0mv8E1SJ3OcNziu82hXPU63OZFPKRO1MnsgCp3orN-qyUG7x6gU3tZfVRfKA7nr7NrrF750js1YmybxCby49D0RMPYhdGAMITrh9FaLvoOsZcBc5KhzrWGAtEBYCxL7PYuqARS6w0AGztgs4DeaIX2dh-BjHwfXtaTi82-G7paSd5LWTvPZP3gRpcAbOXlwC</recordid><startdate>20170921</startdate><enddate>20170921</enddate><creator>P., Swathi</creator><creator>Vidyadhara, S.</creator><creator>Sasidhar, R. L. C.</creator><creator>Chakravarthi, K. Kalyan</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20170921</creationdate><title>METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENTECAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC</title><author>P., Swathi ; Vidyadhara, S. ; Sasidhar, R. L. C. ; Chakravarthi, K. Kalyan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c981-c8e68cc9505ab99fdcdf4c5e7e19e4d43aac046cc822481ec47e3acdc4aad3513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>P., Swathi</creatorcontrib><creatorcontrib>Vidyadhara, S.</creatorcontrib><creatorcontrib>Sasidhar, R. L. C.</creatorcontrib><creatorcontrib>Chakravarthi, K. Kalyan</creatorcontrib><collection>CrossRef</collection><jtitle>International journal of current pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>P., Swathi</au><au>Vidyadhara, S.</au><au>Sasidhar, R. L. C.</au><au>Chakravarthi, K. Kalyan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENTECAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC</atitle><jtitle>International journal of current pharmaceutical research</jtitle><date>2017-09-21</date><risdate>2017</risdate><spage>107</spage><epage>111</epage><pages>107-111</pages><issn>0975-7066</issn><eissn>0975-7066</eissn><abstract>Objective: The objective and purpose of the analysis have sensibly assessed by selecting of a rapid and sensitive RP-HPLC method for Entecavir in bulk and pharmaceutical dosage form by using the most commonly employed C-18column with UV detection.Methods: In estimation by RP-HPLC method Agilent 1120 compact LC system with variable programmable UV detector and Rheodyne injector with 20 µl fixed loop was used for the chromatographic separation. The mode of operation was isocratic with the components of a solution consisting of methanol: acetonitrile(70:30v/v) and triethanolamine (2-4drops)at the flow rate of 1.2 ml/min and run time was 10 min. Forced degradation studies were conducted to evaluate the stability and specificity of the method along with the validation parameters.Results: Validation parameters of HPLC were found at a detection wavelength of 255 nm. Linearity was observed with the concentration range (Beer’s law range) 20-100µg/ml with R2=0.9991. Robustness with detection wavelengths 253 and 257 nm with a flow rate of 1 ml/min and 1.4 ml/min showed good results. The retention time of the drug was 2.64 min and assay showed 98.1%.Conclusion: The proposed RP-HPLC method was validated as per the ICH Q2B Guidelines, and was found to be applicable for routine quantitative analysis of Entecavir by RP-HPLC using UV detector in pharmaceutical dosage forms. The results of linearity, precision, accuracy and specificity, were proved, that does not exceed certain specified limits. The method provides selective quantification with no interference from other formulation excipients. The proposed method was highly sensitive, reproducible, reliable, robust and specific. Therefore, this method is a simple, rapid analysis may actually be more desirable than a more complicated and time-consuming process. The degradation studies at various stress conditions like thermal and hydrolytic, drug gets degraded at a temperature of 80 °c and refluxing with water at 70 °c for 24hours. </abstract><doi>10.22159/ijcpr.2017v9i5.22151</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0975-7066
ispartof International journal of current pharmaceutical research, 2017-09, p.107-111
issn 0975-7066
0975-7066
language eng
recordid cdi_crossref_primary_10_22159_ijcpr_2017v9i5_22151
source Free E-Journal (出版社公開部分のみ)
title METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENTECAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A02%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=METHOD%20DEVELOPMENT%20AND%20VALIDATION%20FOR%20THE%20ESTIMATION%20OF%20ENTECAVIR%20IN%20BULK%20AND%20PHARMACEUTICAL%20DOSAGE%20FORMS%20BY%20RP-HPLC&rft.jtitle=International%20journal%20of%20current%20pharmaceutical%20research&rft.au=P.,%20Swathi&rft.date=2017-09-21&rft.spage=107&rft.epage=111&rft.pages=107-111&rft.issn=0975-7066&rft.eissn=0975-7066&rft_id=info:doi/10.22159/ijcpr.2017v9i5.22151&rft_dat=%3Ccrossref%3E10_22159_ijcpr_2017v9i5_22151%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true